Correction: Efficacy and safety of ayurvedic intervention (Sarpgandha Mishran) vs. amlodipine for stage‑i primary hypertension‑ study protocol for a prospective double‑dummy, double‑blind, placebo‑controlled randomized clinical trial.

IF 3.3 2区医学 Q1 INTEGRATIVE & COMPLEMENTARY MEDICINE

BMC Complementary Medicine and Therapies Pub Date : 2025-05-19 DOI:10.1186/s12906-025-04921-y

Babita Yadav, Bcs Rao, Rajiv Narang, Sophia Jameela, Shruti Khanduri, Sakshi Sharma, Drishya Dinesh, Arti Srivastava, Richa Bhardwaj, Bharti Gupta, N Srikanth, Dharamvir Singh Arya, Richa Singhal

引用次数: 0

查看原文本刊更多论文

修正：阿育吠陀干预（Sarpgandha Mishran）与氨氯地平治疗i期原发性高血压的疗效和安全性——一项前瞻性双假人、双盲、安慰剂对照随机临床试验研究方案。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

BMC Complementary Medicine and Therapies INTEGRATIVE & COMPLEMENTARY MEDICINE-

CiteScore

6.10

自引率

2.60%

发文量

300

审稿时长

19 weeks

期刊介绍：